11 – 20 of 657
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Plasma MTBR-tau243 biomarker identifies tau tangle pathology in Alzheimer's disease
- Contribution to journal › Article
-
Mark
GBA1 T369M and Parkinson's disease - Further evidence of a lack of association in the Swedish population
- Contribution to journal › Article
-
Mark
Balance and gait disorders in de novo Parkinson’s disease : support for early rehabilitation
- Contribution to journal › Article
-
Mark
Associations between structural brain changes and blood neurofilament light chain protein in treatment-resistant schizophrenia
- Contribution to journal › Article
-
Mark
Visual Classification of Tau-PET Detects 4 Subtypes With Different Long-Term Outcomes
- Contribution to journal › Article
-
Mark
CSF markers of neuroinflammation, synaptic dysfunction and [18F]DOPA-PET in Parkinson's disease
- Contribution to journal › Article
-
Mark
Comparison of plasma ALZpath p-Tau217 with Lilly p-Tau217 and p-Tau181 in a neuropathological cohort
- Contribution to journal › Article
-
Mark
Predictive Value of Plasma Biomarkers in Tau-PET Transitions
- Contribution to journal › Article
-
Mark
Plasma tau biomarkers for biological staging of Alzheimer’s disease
- Contribution to journal › Article
-
Mark
Olfactory dysfunction and amyloid-positivity in Parkinson’s disease—longitudinal analysis of cognitive decline and cerebrospinal fluid markers
- Contribution to journal › Article
